Alisertib: Difference between revisions

Latest revision as of 10:04, 19 December 2018

Description

"Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer." Source: [ http://www.drugbank.ca/drugs/DB05220]

Alternative names

MLN8237
MLN-8237
1028486-01-2

Usage Notes

References

> 7 Xenbase articles contain a reference to Alisertib or MLN8237 according to textpresso

Back To Small Molecules Home Page

Revision as of 10:03, 19 December 2018 (view source) imported>Xenbase (Created page with "==Description== "Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer." Source: [ http://www.drugbank.ca/drugs/DB052...")		Latest revision as of 10:04, 19 December 2018 (view source) imported>Xenbase No edit summary
Line 4:		Line 4:


	[[File:Screen Shot 2018-09-17 at 9.14.50 AM.png\|frame\|right\| structure, image from PubChem]]		[[File:Screen Shot 2018-12-19 at 11.03.46 AM.png\|frame\|right\| structure, image from PubChem]]

	==Alternative names==		==Alternative names==